![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
PG Bray, SR Hawley and SA Ward
Department of Pharmacology and Therapeutics, University of Liverpool, UK.
The relationship between antimalarial activity and drug accumulation of chloroquine and amodiaquine was evaluated with four chloroquine- resistant and two chloroquine-susceptible isolates of Plasmodium falciparum. Susceptibility of the strains to amodiaquine was correlated with susceptibility to chloroquine (r2 = 0.96). Similarly, accumulation of amodiaquine was correlated with accumulation of chloroquine (r2 = 0.94). Accumulation of both chloroquine and amodiaquine was significantly reduced in chloroquine-resistant isolates (p < 0.005). For the panel of isolates, the accumulation ratio of both drugs was inversely proportional to drug susceptibility (r2 = 0.963 and 0.994 for amodiaquine and chloroquine, respectively). Time course studies highlighted a reduced initial rate of amodiaquine accumulation in chloroquine-resistant isolates compared with chloroquine-susceptible isolates, with no evidence of an enhanced drug efflux rate. Daunomycin, a modulator of parasite chloroquine transport, significantly increased steady state accumulation of both drugs in chloroquine-resistant isolates and, to a lesser extent, in chloroquine-susceptible isolates. Furthermore, daunomycin increased the initial rate of accumulation of amodiaquine in both chloroquine-resistant and chloroquine-susceptible isolates. Resistance to 4-aminoquinoline drugs is associated with reduced drug permeability rather than enhanced cellular exit of preaccumulated drug, and daunomycin seems to increase the permeability of parasites to aminoquinolines. A new model of 4-aminoquinoline resistance is proposed to take account of these and earlier observations.
This article has been cited by other articles:
|
|
 |
|
  S. NKHOMA, M. MOLYNEUX, and S. WARD IN VITRO ANTIMALARIAL SUSCEPTIBILITY PROFILE AND PRCRT/PFMDR-1 GENOTYPES OF PLASMODIUM FALCIPARUM FIELD ISOLATES FROM MALAWI Am J Trop Med Hyg, June 1, 2007; 76(6): 1107 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. KONGTHAISONG, K. NA-BANGCHANG, M. MUNGTHIN, N. SINCHAIPANID, and P. TAN-ARIYA COMPARISON OF THE BIOEQUIVALENCE OF THREE ORAL FORMULATIONS OF DIHYDROARTEMISININ BASED ON EX VIVO BLOOD SCHIZONTOCIDAL ACTIVITIES AGAINST PLASMODIUM FALCIPARUM Am J Trop Med Hyg, December 1, 2004; 71(6): 703 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Pradines, T. Fusai, W. Daries, V. Laloge, C. Rogier, P. Millet, E. Panconi, M. Kombila, and D. Parzy Ferrocene-chloroquine analogues as antimalarial agents: in vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum J. Antimicrob. Chemother., August 1, 2001; 48(2): 179 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Bray, O. Janneh, K. J. Raynes, M. Mungthin, H. Ginsburg, and S. A. Ward Cellular Uptake of Chloroquine Is Dependent on Binding to Ferriprotoporphyrin IX and Is Independent of NHE Activity in Plasmodium falciparum J. Cell Biol., April 19, 1999; 145(2): 363 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Hawley, P. G. Bray, M. Mungthin, J. D. Atkinson, P. M. O'Neill, and S. A. Ward Relationship between Antimalarial Drug Activity, Accumulation, and Inhibition of Heme Polymerization in Plasmodium falciparum In Vitro Antimicrob. Agents Chemother., March 1, 1998; 42(3): 682 - 686. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
